Home Our services Syndicated insights & RWE Smart Analyst Smart Analyst Oncology Navigator

Smart Analyst Oncology Navigator.

Unique proprietary platform.

Robust trial data visualization platform offering a "tumor" and "IO" lens

Unique proprietary platform that collects and links outcomes (efficacy, safety and key milestone survival rates) to granular clinical programs and program design. Rapid results allow focus on foundational analysis and strategy development.

Further information:

  • Updated Monthly
    New trials and read-outs
    Changes in trial design
    Updated recruitment status
    Additions to patient cohorts
  • After key conferences
    AACR, ASCO, GI-ASCO, GU-ASCO, EHA, ESMO, ICLLM, WCLC, SABCS, SITC, ASH
  • Dataset Differentiators
    Outcomes by molecule, patient characteristics, segments, prior therapy and immunotherapy resistance
    Outcomes with comparator at each endpoint
    Milestone data
    Review criteria followed to report outcomes

Find out more.

Request more information about Oncology Navigator or arrange a demo.

Our other reports and services.

Experts in syndicated research.

Brendan Langan

Senior Commercial and Strategy Director

About Brendan.

Brendan has over 20 years’ of progressive experience serving as a partner to stakeholders in life sciences, pharmaceutical, biotech and healthcare. His research experience spans all facets of qualitative and quantitative primary market research, competitive intelligence, secondary and syndicated research.

brendan.langan@researchpartnership.com